Andere talen Hongchang International Co., Ltd

Aandelen

HCIL

US42831T2024

Beurs gesloten - OTC Markets Andere beurzen 15:31:03 06-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,2501 ^USD	+12,35%		+12,35%	-28,30%

01/04	Hongchang International Co., Ltd rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
01/04	Hongchang International Co, Ltd kondigt wijzigingen in de raad van bestuur aan	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Hongchang International Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
Hongchang International Co., Ltd Announces Board Changes	01/04
Hongchang International Co., Ltd. has Changed its Ticker to HCIL from HYBT	28/11
Heyu Biological Technology Corporation has Changed its Name to Hongchang International Co., Ltd	21/11
Hongchang International Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Hong Chang Biotechnologies (HK) Limited completed the acquisition of Heyu Biological Technology Corporation (OTCPK:HYBT.D) in a reverse merger transaction.	04-09-23
Heyu Biological Technology Corporation Appoints Zengqiang Lin as the Chief Executive Officer	23-08-23
Heyu Biological Technology Corporation Announces Board and Executive Changes	23-08-23
Heyu Biological Technology Corporation Appoints Wendy Wei Li as the Chief Financial Officer of the Company	23-08-23
Hong Chang Biotechnologies (HK) Limited entered into an agreement to acquire Heyu Biological Technology Corporation (OTCPK:HYBT.D) in a reverse merger transaction for HKD 4.4 billion.	23-08-23
Heyu Biological Technology Corporation Reports Earnings Results for the Half Year Ended June 30, 2023	16-08-23
Insider Buy: Heyu Biological Technology	31-05-23
Heyu Biological Technology Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	12-05-23
HEYU BIOLOGICAL TECHNOLOGY CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	23-03-23
Heyu Biological Technology Corporation Auditor Raises 'Going Concern' Doubt	23-03-23
HEYU BIOLOGICAL TECHNOLOGY : ANNOUNCES APPOINTMENT OF NEW INDEPENDENT DIRECTOR - Form 8-K	22-02-23
HEYU BIOLOGICAL TECHNOLOGY CORP : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	22-02-23
Heyu Biological Technology Corporation Appoints Zengqiang Lin as an Independent Director of the Company	22-02-23
HEYU BIOLOGICAL TECHNOLOGY CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	13-02-23
Heyu Biological Technology Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	13-02-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Hongchang International Co., Ltd

Aandelen

HCIL

US42831T2024

Andere talen

Filters